Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.
暂无分享,去创建一个
L. Gesualdo | F. Schena | A. Loverre | A. Crovace | P. Ditonno | E. Ranieri | P. Pontrelli | G. Stallone | B. Infante | A. Schena | S. di Paolo | C. Capobianco | M. Ursi | S. Palazzo | M. Battaglia | F. Selvaggi | G. Grandaliano | Silvano Palazzo | Michele Ursi
[1] M. Mangino,et al. Is ischemic preconditioning of the kidney clinically relevant? , 2003, Surgery.
[2] L. Brass,et al. Protease activated receptors: theme and variations , 2001, Oncogene.
[3] L. Pfeffer,et al. NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.
[4] C. Napoli,et al. Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Villa,et al. Multiparametric monitoring of ischemia-reperfusion in rat kidney: effect of ischemic preconditioning , 2003, Transplantation.
[6] R. Shenkar,et al. Involvement of Phosphoinositide 3-Kinases in Neutrophil Activation and the Development of Acute Lung Injury1 , 2001, The Journal of Immunology.
[7] J. Harlan,et al. The Role of Leukocyte and Endothelial Adhesion Molecules in Ischemia – Reperfusion Injury , 1997, Thrombosis and Haemostasis.
[8] Tobias Schmelzle,et al. TOR, a Central Controller of Cell Growth , 2000, Cell.
[9] L. Truong,et al. Sirolimus May Promote Thrombotic Microangiopathy , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] M. Razzaque,et al. Pathological significance of renal expression of NF-kappa B. , 2003, Contributions to Nephrology.
[11] G. Koehl,et al. Rapamycin-Induced Endothelial Cell Death and Tumor Vessel Thrombosis Potentiate Cytotoxic Therapy against Pancreatic Cancer , 2004, Clinical Cancer Research.
[12] L. Gesualdo,et al. Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis. , 2003, Journal of the American Society of Nephrology : JASN.
[13] B. Lucchesi,et al. Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. , 1994, Circulation research.
[14] M. Karin,et al. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion , 2003, Nature Medicine.
[15] R. Santucci,et al. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. , 2000, The American journal of pathology.
[16] D. Gjertson,et al. The hyperfiltration hypothesis in human renal transplantation. , 1994, Transplantation.
[17] A. Vandewalle,et al. To what extent can limiting cold ischaemia/reperfusion injury prevent delayed graft function? , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[19] Silvano Sozzani,et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .
[20] M. Razzaque,et al. Pathological Significance of Renal Expression of NF-κB , 2003 .
[21] L. Gesualdo,et al. Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. , 2000, Journal of the American Society of Nephrology : JASN.
[22] A. Vollmar,et al. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[23] G. Hansson,et al. Nuclear factor kappa-B and the heart. , 2001, Journal of the American College of Cardiology.
[24] I. Singh,et al. Ischemia-reperfusion injury: biochemical alterations in peroxisomes of rat kidney. , 1992, Archives of biochemistry and biophysics.
[25] S. Tullius,et al. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. , 1995, Transplantation.
[26] R. Kitsis,et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.
[27] S. Cook,et al. Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart* , 2002, The Journal of Biological Chemistry.
[28] A. Vollmar,et al. α-Lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway , 2003 .
[29] S. Ward,et al. Phosphoinositide 3‐kinase: a key biochemical signal for cell migration in response to chemokines , 2000, Immunological reviews.
[30] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[31] J. Downward. Mechanisms and consequences of activation of protein kinase B/Akt. , 1998, Current opinion in cell biology.
[32] 島村 治子. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-κB and Bad , 2003 .
[33] E. Kandel,et al. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. , 1999, Experimental cell research.
[34] Yang Shi,et al. Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt Pathway* , 2003, Journal of Biological Chemistry.
[35] K. Kamiński,et al. Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury. , 2002, International journal of cardiology.
[36] W. Bahou. Protease-activated receptors. , 2003, Current topics in developmental biology.
[37] A. Melk,et al. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. , 1999, Journal of the American Society of Nephrology : JASN.
[38] R. Valeri,et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. , 2001, American journal of physiology. Renal physiology.
[39] Bernd R. Binder,et al. Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus* , 2002, The Journal of Biological Chemistry.
[40] L. Gesualdo,et al. Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. , 2004, Journal of the American Society of Nephrology : JASN.
[41] R. Abraham,et al. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells. , 1995, Progress in cell cycle research.
[42] K. Messmer,et al. Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox". , 1992, The American journal of physiology.
[43] B. Molitoris,et al. Injury of the renal microvascular endothelium alters barrier function after ischemia. , 2003, American journal of physiology. Renal physiology.
[44] N. Polissar,et al. Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. , 2003, Journal of the American Society of Nephrology : JASN.
[45] K. Abe,et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. , 2000, The Journal of clinical investigation.
[46] R. Zager,et al. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. , 1994, Kidney international.
[47] K. Park,et al. Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. , 2003, Kidney international.
[48] R. Guttmann,et al. Effects of initial ischemia/reperfusion injury on the transplanted kidney. , 1997, Transplantation.
[49] M. Feldmann,et al. NF-κB-Inducing Kinase Is Dispensable for Activation of NF-κB in Inflammatory Settings but Essential for Lymphotoxin β Receptor Activation of NF-κB in Primary Human Fibroblasts1 , 2001, The Journal of Immunology.
[50] J. Camardo,et al. Rapamycin: clinical results and future opportunities. , 2001, Transplantation.
[51] Y. Terada,et al. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. , 2003, Journal of the American Society of Nephrology : JASN.
[52] T. Asahara,et al. Prevention of ischemia–reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor1 , 2003, Transplantation.
[53] Daniel Kalman,et al. Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis , 2003, The Journal of cell biology.
[54] K. Webster,et al. Reperfusion-Activated Akt Kinase Prevents Apoptosis in Transgenic Mouse Hearts Overexpressing Insulin-Like Growth Factor-1 , 2001, Circulation research.